Investing Profile

Cheryl Zimberlin

InvestorVC
Investment Director at M Ventures (Merck)
m-ventures.com/enAmsterdam, Netherlands
Photo of Cheryl Zimberlin, Investor at M Ventures (Merck)

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
Hotmail Network
4899 CONNECTIONS
M Ventures Network
23 CONNECTIONS
cb
$100K - $5.0M
$1.5M
1
€600M
CompanyStageDateRound SizeTotal Raised
ImmuneBridge
SeedJan 2023$12M
$20M
Co-investors: Dylan Morris (Insight Partners), Semyon Dukach (One Way Ventures)
Analyst M VenturesPresent
Associate M VenturesPresent
Board Observer Inthera Bioscience AGPresent
Board Member Rewind TherapeuticsPresent
Board Member Calypso BiotechPresent
Board Observer ApoGen BiotechnologiesPresent
Board Member Vaximm AGPresent
Principal M VenturesPresent
Board Member Indi MolecularPresent
Board Observer Multitude TherapeuticsPresent
Board Member HotmailPresent
Investment Director M VenturesPresent
Board Member Scipio BiosciencePresent
Board Member ImmuneBridgePresent
Executive Director HotmailPresent
Fund Manager HotmailPresent
Founder HotmailPresent
University College Utrecht Bachelor of Science (BSc) Biologie (Biology)
Wageningen University & Research Master of Science (MSc) Biotechnology